Your browser doesn't support javascript.
loading
Implementing Pharmacogenetic Testing in Gastrointestinal Cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 Screening to Guide Chemotherapy Dosing.
Varughese, Lisa A; Bhupathiraju, Madhuri; Hoffecker, Glenda; Terek, Shannon; Harr, Margaret; Hakonarson, Hakon; Cambareri, Christine; Marini, Jessica; Landgraf, Jeffrey; Chen, Jinbo; Kanter, Genevieve; Lau-Min, Kelsey S; Massa, Ryan C; Damjanov, Nevena; Reddy, Nandi J; Oyer, Randall A; Teitelbaum, Ursina R; Tuteja, Sony.
Afiliação
  • Varughese LA; Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Bhupathiraju M; Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Hoffecker G; Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Terek S; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, United States.
  • Harr M; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, United States.
  • Hakonarson H; Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, United States.
  • Cambareri C; Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, United States.
  • Marini J; Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, United States.
  • Landgraf J; Information Services Applications, Penn Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Chen J; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Kanter G; Division of Medical Ethics and Health Policy, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Lau-Min KS; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Massa RC; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Damjanov N; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Reddy NJ; Ann B. Barshinger Cancer Institute, Lancaster General Health, Penn Medicine, Lancaster, PA, United States.
  • Oyer RA; Ann B. Barshinger Cancer Institute, Lancaster General Health, Penn Medicine, Lancaster, PA, United States.
  • Teitelbaum UR; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Tuteja S; Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Front Oncol ; 12: 859846, 2022.
Article em En | MEDLINE | ID: mdl-35865463
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Screening_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article